Dysphagia Management Market: By Product Type (Drugs (Proton Pump Inhibitors), Feeding Tubes [Naso-Gastric Tubes and PEG Tubes], Nutritional Solutions [Thickeners, Beverages, and Puree]), By Indication (Oropharyngeal Dysphagia, Esophageal Dysphagia, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Speciality Clinics, and Others), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Dysphagia Management Market was valued at USD 726.5 million in 2022 and is poised to grow at a significant CAGR of 12.9% over 2023-2029. Dysphagia is becoming more common as the prevalence of various malignancies, particularly oral cancer, rises. Furthermore, some cancer treatments can create swallowing problems as a side effect, necessitating the usage of an appropriate dysphagia supplement to avoid further complications. Dysphagia is more common in persons who have Parkinson's disease or stroke. One of the most severe adverse effects of smoking cigarettes for an extended period is dysphagia. While smoking tobacco kills around 6 million people each year, the dysphagia management market is progressively growing due to the increased frequency of oropharyngeal malignancies. Because of the devastating consequences of choking, dysphagia management has become critical in geriatric and juvenile populations. Proton pump inhibitors, feeding tubes, and nutritional treatments such as thickeners and beverages are some alternatives for dysphagia management. The appropriate dysphagia management option is determined by the severity of the condition.

According to the World Heart Association, 15 million people have a stroke each year, with 6 million dying and 6 million becoming disabled, resulting in eyesight loss and speech impairment.As a result, the rising prevalence of stroke-related dysphagia and associated pharyngeal and laryngeal problems is propelling the dysphagia management market forward. Market players can concentrate on launching over-the-counter medications to treat dysphagia. For example, most Western European pharmaceutical corporations, such as Bayer AG and Johnson & Johnson, are expanding into the OTC market as a contiguous out-of-pocket sector. Moreover, the market is likely to benefit from establishing standard definitions of dysphagia and malnutrition, an in-depth analysis of the link between causes and outcomes of dysphagia and emphasizing the significance of efficient and accurate screening. One of the most essential methods used by prominent market players in the dysphagia management landscape is to focus their efforts on acquiring smaller players in the dysphagia market. Furthermore, they are likely to focus on company expansion in the dysphagia management field outside of their major geographic markets.

Dysphagia Management Market Key Developments:
  • In September 2020, Thick-It Brand announced the launch of a variety pack of dysphagia nutrition products. Purée Protein, Purée Vegetable, and Ready-to-Drink are all available in the new packets. The ready-to-drink alternatives are available in IDDSI Level 2 Mildly Thick (nectar) and IDDSI Level 3  Moderately Thick (honey) consistencies and feature the newly reformulated Thick-It Clear Advantage drinks. Purées can be found in IDDSI Lsevel 4 Puree.

Dysphagia Management Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.9%

Largest Market

Asia Pacific

Fastest Growing Market

North America

Dysphagia Management Market Dynamics

The rising number of people addicted to smoking is expected to impact the dysphagia market's growth. Dysphagia is one of the most dangerous side effects of smoking cigarettes for a lengthy period. While tobacco usage kills nearly 6 million people each year, the rising prevalence of oropharyngeal cancer drives the dysphagia market forward. The market's expansion is projected to be restrained by the side effects and pain of dysphagia medications and tubes. Long-term use of dysphagia medicines like proton pump inhibitors is linked to a higher risk of hip fracture due to decreased calcium and iron absorption, as well as an increased risk of opportunistic infections with S. pneumoniae and C. difficult due to weakened natural gut flora.

Dysphagia Management Market Segmentation

By Product Type

  • Drugs
  • Feeding Tubes
  • Nutritional Solutions

By Indication Type

  • Oropharyngeal Dysphagia
  • Esophageal Dysphagia
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Speciality Clinics
  • Others

Frequently Asked Questions

The dysphagia management market is projected to expand at a CAGR of 12.9% during the forecast period

Eisai Co. Ltd., Becton, Dickinson and Company (BD), AstraZeneca Plc., Cipla Limited, Nestlé (Nestlé Health Science)

North America is the fastest-growing region for dysphagia management market

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2.  Global Dysphagia Management Market Introduction 
2.1. Global Dysphagia Management Market  - Taxonomy
2.2. Global Dysphagia Management Market  - Definitions
2.2.1. By Product Type
2.2.2. By Indication
2.2.3. By Distribution Channel
2.2.4. By Region
3. Global Dysphagia Management Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
4. Global Dysphagia Management Market  By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
4.1. Drugs
4.1.1. Proton Pump Inhibitors
4.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.1.1.3. Market Opportunity Analysis 
4.2. Feeding Tubes
4.2.1. Naso-Gastric Tubes and
4.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.2.1.3. Market Opportunity Analysis 
4.2.2. PEG Tubes
4.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.2.2.3. Market Opportunity Analysis 
4.3. Nutritional Solutions
4.3.1. Thickeners,
4.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.3.1.3. Market Opportunity Analysis 
4.3.2. Beverages, and
4.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.2.3. Market Opportunity Analysis 
4.3.3. Puree
4.3.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.3.3. Market Opportunity Analysis 
5. Global Dysphagia Management Market  By Indication, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Oropharyngeal Dysphagia
5 1 1  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Esophageal Dysphagia
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Dysphagia Management Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Hospital Pharmacies
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Retail Pharmacies
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Drug Stores
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Speciality Clinics
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.  Global Dysphagia Management Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Latin America
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. MEA
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1. Drugs
8.1.1.1. Proton Pump Inhibitors 
8.1.2. Feeding Tubes
8.1.2.1. Naso-Gastric Tubes and
8.1.2.2. PEG Tubes
8.1.3. Nutritional Solutions
8.1.3.1. Thickeners,
8.1.3.2. Beverages, and
8.1.3.3. Puree
8.2. Indication Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1. Oropharyngeal Dysphagia
8.2.2. Esophageal Dysphagia
8.2.3. Others
8.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Drug Stores
8.3.4. Speciality Clinics
8.3.5. Others
8.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.4.1. USA
8.4.2. Canada
9. Europe Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1. Drugs
9.1.1.1. Proton Pump Inhibitors 
9.1.2. Feeding Tubes
9.1.2.1. Naso-Gastric Tubes and
9.1.2.2. PEG Tubes
9.1.3. Nutritional Solutions
9.1.3.1. Thickeners,
9.1.3.2. Beverages, and
9.1.3.3. Puree
9.2. Indication Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1. Oropharyngeal Dysphagia
9.2.2. Esophageal Dysphagia
9.2.3. Others
9.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Drug Stores
9.3.4. Speciality Clinics
9.3.5. Others
9.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1. Germany
9.4.2. France
9.4.3. Italy
9.4.4. Spain
9.4.5. UK
9.4.6. Rest of Europe
10. Asia Pacific Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1. Drugs
10.1.1.1. Proton Pump Inhibitors 
10.1.2. Feeding Tubes
10.1.2.1. Naso-Gastric Tubes and
10.1.2.2. PEG Tubes
10.1.3. Nutritional Solutions
10.1.3.1. Thickeners,
10.1.3.2. Beverages, and
10.1.3.3. Puree
10.2. Indication Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1. Oropharyngeal Dysphagia
10.2.2. Esophageal Dysphagia
10.2.3. Others
10.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Drug Stores
10.3.4. Speciality Clinics
10.3.5. Others
10.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1. China
10.4.2. Japan
10.4.3. South Korea
10.4.4. India
10.4.5. Rest of APAC
11. Latin America Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1. Drugs
11.1.1.1. Proton Pump Inhibitors 
11.1.2. Feeding Tubes
11.1.2.1. Naso-Gastric Tubes and
11.1.2.2. PEG Tubes
11.1.3. Nutritional Solutions
11.1.3.1. Thickeners,
11.1.3.2. Beverages, and
11.1.3.3. Puree
11.2. Indication Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1. Oropharyngeal Dysphagia
11.2.2. Esophageal Dysphagia
11.2.3. Others
11.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Drug Stores
11.3.4. Speciality Clinics
11.3.5. Others
11.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of Latin America
12. MEA Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1. Drugs
12.1.1.1. Proton Pump Inhibitors 
12.1.2. Feeding Tubes
12.1.2.1. Naso-Gastric Tubes and
12.1.2.2. PEG Tubes
12.1.3. Nutritional Solutions
12.1.3.1. Thickeners,
12.1.3.2. Beverages, and
12.1.3.3. Puree
12.2. Indication Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1. Oropharyngeal Dysphagia
12.2.2. Esophageal Dysphagia
12.2.3. Others
12.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Drug Stores
12.3.4. Speciality Clinics
12.3.5. Others
12.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of MEA
13.  Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Eisai Co. Ltd.
13.2.2. Becton
13.2.3. Dickinson and Company (BD)
13.2.4. AstraZeneca Plc.
13.2.5. Cipla Limited
13.2.6. Nestlé (Nestlé Health Science)
13.2.7. Kent Corporation
13.2.8. Danone
13.2.9. Cook Group
14.  Research Methodology
15.  Key Assumptions and Acronyms
  • Eisai Co. Ltd.
  • Becton
  • Dickinson and Company (BD)
  • AstraZeneca Plc.
  • Cipla Limited
  • Nestlé (Nestlé Health Science)
  • Kent Corporation
  • Danone
  • Cook Group

Adjacent Markets